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a  b  s  t  r  a  c  t
Objective: To evaluate the approach to palliative care for hematological oncology patients in
the  pediatric ward of a tertiary hospital.
Methods: This was a retrospective, descriptive study of 29 hematological oncology patients
who  died between 2009 and 2011. Data regarding the approach and prevalence of pain, preva-
lence of other symptoms, multidisciplinary team participation, communication between
staff  and family and limited invasive therapy were collected from the medical records.
Results: Twenty-seven (93.1%) patients displayed disease progression unresponsive to cura-
tive treatment. The median age at death was ten years old. Pain was the most prevalent
symptom with all patients who reported pain receiving analgesic medications. The majority
took weak (55.2%) and/or strong (65.5%) opioids. The patients were followed by pediatricians
and a pediatric hematologist/oncologist. Participation of other professionals was also doc-
umented: 86.2% were followed by social services and 69% by psychologists, among others.
There were explicit descriptions of limitation of invasive therapy in the medical records of
26  patients who died with disease progression. All these decisions were shared with the
families.
Conclusion: Although the hospital where this study was conducted does not have a special-
ized  team in pediatric palliative care, it meets all the requirements for developing a speciﬁc
program. The importance of approaching pain and other prevalent symptoms in children
with  cancer involving a comprehensive multidisciplinary team is evident. Discussions were
had with most of the families on limiting invasive therapy, but no record of a well-deﬁned
and coordinated treatment plan for palliative care was found.©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
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dents fully supervised by preceptors on the hospital’s clinical
staff. All patients were assisted by pediatric hematologists
or oncologists as required by their underlying diseases. The
Table 1 – Characteristics of the 29 hematological
oncology patients who progressed to death.
Characteristics
Gender (male:female) 18:11
Age at time of diagnosis (years)
Median 6
Variation 1–16
Interquartile range (25–75%) 2.5–9.5
Age at time of death (years)
Median 10
Variation 1–17
Interquartile range (25–75%) 4.5–13
Symptoms reported throughout Hospitalization (n◦)
Median 4
Variation 0–8
Interquartile range (25–75%) 3–6
Interval between diagnosis of and death (years)
Median 1.1
Variation 0.1–10
Interquartile range (25–75%) 0.7–3.8
Duration of hospitalization when patient died (days)404  rev bras hematol hem
Introduction
Palliative care in pediatrics is, according to the World Health
Organization, active and total care delivered to a child in rela-
tion to his or her body, mind and soul, with support provided to
the whole family. The focus of this approach is early identiﬁ-
cation and treatment of pain and other symptoms with a view
to providing patients and their families with the best quality
of life possible.1
There are currently many  children in need of palliative
care2 including patients with neoplasms. Every year, 200,000
children and adolescents are diagnosed with cancer around
the world. In Brazil, the mortality rate of children and adoles-
cents aged between one and 19 due to cancer was 8% in 2005
making this the second leading cause of death and the ﬁrst
leading cause of death by disease in this population. Global
initiatives to provide care for these children are, therefore,
necessary and urgent.3,4
This study aimed to evaluate the approach of palliative care
in hematological oncology patients who progressed to death
in the pediatric ward of a tertiary hospital.
It is important to state that palliative care should be
introduced at the time of diagnosis. However, as cura-
tive measures decrease, palliative care becomes an absolute
necessity5 and for this reason, the study sample was com-
posed of patients who  died.
Methods
This was a retrospective, descriptive Study that included
all under 18-year-old patients diagnosed with hematological
oncology diseases who died in the pediatric ward of the Hos-
pital das Clínicas at Universidade Federal de Minas Gerais
(HC-UFMG) between 2009 and 2011.
Patients with other diseases who  also needed palliative
care and progressed to death were excluded as were patients
with hematological oncology diseases who died in their
homes, emergency services, intensive care units or in other
hospitals.
Data were collected through analysis of the medical
records. These data refer to the hospitalization during which
the patients died.
The assessed data relate to the main items that con-
stitute good assistance in palliative care: approach to pain,
prevalence of pain and other symptoms, involvement of a mul-
tidisciplinary team, communication between medical staff
and family/patient on the case and disease progression, the
family’s desire to go home, patient follow-up by the home care
service and limitation of invasive therapy.
The study was approved by the hospital’s Research Ethics
Committee, which waived informed consent.
ResultsBetween 2009 and 2011, 44 deaths were recorded in the pedi-
atric ward of the HC-UFMG. Of those, 29 (66%) were patients
with hematological oncology diseases, who were included in
the study. 2 0 1 4;3  6(6):403–408
Of the 29 patients that died, the median ages at the time
of diagnosis and death were six and ten years, respectively.
Forty-ﬁve per cent had hematological diseases (aplastic ane-
mia  or leukemia) and 55% had solid tumors. Twenty-seven
(93.1%) displayed disease progression unresponsive to curative
treatment. Of these, three patients received chemotherapy as
a palliative measure and only one received chemotherapy with
curative prospects, even with disease progression and limited
invasive therapy.
Ten patients (34.4%) displayed neurological sequelae, with
varying degrees of cognitive deﬁcit. Six patients were tra-
cheostomized (all with neurological sequelae: #4, #9, #12, #16,
#18, #24), thirteen had been using an enteral tube and one had
a gastrostomy.
The median duration of hospitalization was 40 days. Eight
patients (27.5%) were admitted into the intensive care unit at
least once during hospitalization.
Data regarding the characterization of the sample are
shown in Tables 1 and 2.
The median number of symptoms displayed per patient
was four. The main symptoms and their prevalences are listed
in Table 3. Pain was the most prevalent symptom, reported by
almost 80% of the patients.
All patients reporting pain took analgesic medications:
48.3% took common analgesics but the majority took weak
and/or strong opioids (55.2 and 65.5%, respectively). Three
patients were followed up in the pain clinic. There were no
records of scales or non-pharmacological measures to control
pain being used.
All patients were followed up by general pediatric resi-Median 40
Variation 3–246
Interquartile range (25–75%) 10–66
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Table 2 – Diagnosis, neurological sequelae and use of chemotherapy at the time of death.
Patient # Diagnosis Use of chemotherapy at the time of death Neurological sequelae
3, 7, 21 Aplastic anemia Does not apply No
12, 16, 18 Anaplastic astrocytoma No Yes
9 Adrenocortical carcinoma No Yes
11 Adrenal gland carcinoma No explicit report found Yes
4 Chordoma No Yes
10 Anaplastic ependymoma No explicit report found Yes
5 Glioma No Yes
20 Glioblastoma No No
8 Hepatoblastoma No No
14, 15, 17, 22 ALL No No
25 ALL Curative No
13, 28 ALL Palliative No
2, 19 Acute myeloid leukemia Curative No
23 Myeloid leukemia Palliative No
24 Medulloblastoma No Yes
26 Neuroblastoma No No
27 Neuroﬁbroma No No
29 Osteosarcoma No explicit report found No
6 Brain stem tumor No explicit report found Yes
ALL: acute lymphocytic leukemia.
Table 3 – Prevalence of the symptoms displayed during






Depressed mood 13 44.8
Hyporexia 10 34.5
Anxiety 7 24.1







nvolvement of other medical staff is shown in Table 4. Of
he patients followed up by the psychiatry department, all
ere prescribed psychiatric medications (antidepressants and
nxiolytics) and only one was not simultaneously followed
p by the psychology department. The psychology approach,
Table 4 – Number of patients who  received care from the
different professionals in the multidisciplinary team
during the hospitalization in which the patient died.
Professional n %
Pediatric resident/preceptor 29 100.0
Staff nurses 29 100.0
Social worker 25 86.2
Pediatric oncologist 16 55.0
Pediatric hematologist 13 45.0
Psychologist 20 69.0
Nutritionist 16 55.0
Physical therapist 11 37.9
Occupational therapist 8 27.6
Psychiatrist 5 17.2
Pain clinic 3 10.3
Religious support 1 3.5in its turn, was considered for both family members and
patients.
There were reports of explicit communication between the
medical team and the family on the evolution of the case
and its seriousness, proposed treatment and/or other issues,
including limitations of invasive therapy when indicated in
96.5% (28/29) of the medical records. The medical record of
one patient, who died with disease complications, contained
no reports of communication between the team and his fam-
ily. There were no reports of explicit communication between
the staff and patients in only three cases, who  were aged 14,
15 and 17 years at the time of death (#1, #7 and #27).
Four records described the family’s desire to take the
patient home. All the patients had been undergoing limited
invasive therapy. Four patients were followed up by the home
care team, but their medical records reported no desire of the
family to return home. Of these four patients, the families of
two were visited after death by the home care team. According
to their records, 25 of the 29 children (92.5%) were accompa-
nied by a family member at the time of death, mostly (8/25
cases) only by the mother although in four cases it was only
the father. The father and mother were together in only two
cases. In the other cases, the companion was another family
member or could not be identiﬁed.
Two patients progressed to death with complications sec-
ondary to treatment (#2 and #19), and the other 27 (93.1%) died
due to disease progression. Among those, there were explicit
descriptions by the medical team in their records of limitation
of invasive therapy in 26 cases (96.3%). Of these, limitations of
invasive therapy started before the last hospitalization in ten
patients (38.4%). In all 26 cases, the decision was shared with
the families. Only one child, who had not undergone limita-
tion of invasive therapy, died of disease progression. In this
case, despite the medical staff having asserted that the patient
was not undergoing curative therapy, the parents denied the
unfavorable progression of the disease and did not accept to
limit therapies. This patient, like the other two  who  died with
oter.406  rev bras hematol hem
complications secondary to treatment, were the only ones
who  received cardiopulmonary resuscitation prior to death.
Three patients, who  had been tracheostomized, died on
mechanical ventilation, but none of them received cardiopul-
monary resuscitation.
Despite the limitation of invasive therapy having been
described explicitly in the medical records of 26 children, these
limits were only properly described in 16 (61.5%) patients;
that is, in 38.5% the treating physician did not clearly explain
which therapy should or should not be delivered to the patient,
but used vague terms such as “comfort measures”, “palliative
care” and “limitation of therapeutic efforts”.
Discussion
Currently, around 80% of children and adolescents diagnosed
with cancer can be cured. In spite of the high rates of cure,
cancer-related morbidity and mortality is still signiﬁcant.3,4
Hence, dealing with this new patient proﬁle is a challenge.6
Impeccable control of pain and other symptoms is the main
strategy in the palliative approach.2 In patients with cancer,
pain is an important factor of disease-related suffering.5 As in
most studies, pain was the most prevalent symptom in this
sample.7,10
Assessment of pain should be directed due to the child’s age
and development.2 Whenever possible, the child’s own report
should be esteemed and considered the gold standard.11 It is
recommended to use scales to assess the intensity of pain,
as well as to monitor the progression of treatment.1 However,
these instruments were not used in the ward where the study
was conducted.
Lack of adequate control of pain is at the core of the deﬁ-
ciencies observed in palliative care in developing countries as
the availability and consumption of opioids, considered wide
indicators of cancer-related pain relief, are still restricted.3,12
However, it was observed in this study that the majority of
patients who reported pain were prescribed opioids.
Non-pharmacological measures were not described in the
medical records. Such measures are part of the integral
management of pain and show synergistic effects to drug
treatment.13,14
Not only physical symptoms were identiﬁed in this study.
Psychological symptoms, such as depression and sleep dis-
orders, were also found. These symptoms are described in
the literature as an important cause of suffering for chil-
dren with cancer and they are often not addressed by
doctors.2,8,10
As a way of recognizing the complexity of care needed by
patients with life-threatening diseases, the involvement of
a multidisciplinary team is a prerequisite to deliver quality
assistance.15 It was found in this case study that a signiﬁ-
cant number of patients were assisted by a multidisciplinary
team, but the study design did not allow an evaluation of
whether this follow-up was effective. It was not possible to
evaluate whether there was interaction with the team, which
is essential in multidisciplinary conditions, only by examin-
ing the medical records. The optimal functioning of this team
requires training, communication and the setting of roles and
responsibilities of each member.15 2 0 1 4;3  6(6):403–408
The service provider where this study was conducted
has no specialists in pediatric palliative care, but palliative
interventions should not be limited to specialists.11 General
pediatricians and pediatricians from different ﬁelds should be
able to handle palliative care issues.6
The two patients who died with treatment-related com-
plications were included in this study since palliative care
ought to be initiated at the time of diagnosis.6 Moreover, only
four of the patients who died with disease progression were
receiving chemotherapy when they died. In three of these
cases, chemotherapy was employed as a palliative measure.
Researchers from different countries have shown that chil-
dren who receive end-of-life chemotherapy display a higher
number of symptoms than children who do not, with greater
likelihood of inadequate control of pain.8–10,16 Nevertheless,
the choice of palliative or curative chemotherapy and sus-
pension of chemotherapy is a difﬁcult decision for both the
medical team and the family.17 This difﬁculty may cause med-
ical staff to be reluctant to disclose an unfavorable prognosis
to patients and their parents.16
In most of the cases included in this study, there was evi-
dence of communication between teams and families. Three
records also reported that there was direct communication
with the patients, all of whom were adolescents. However,
these patients did not take part in the decision to limit ther-
apy, only their parents did. Studies emphasize that doctors
and parents ought to talk to sick children about their feelings
and anxieties. Avoiding this sort of communication overlooks
the fact that most of the time they are aware of their situation.6
The medical records of four families clearly reported the
desire to take their children home; all of them were aware that
the disease was progressing. Only by examining the records,
it is impossible to know whether other families had the same
desire. The place of death is an important indicator of end-
of-life quality of care.18 Dying at home, whenever possible, is
preferred by the majority of families of cancer patients.19–21 In
this study, there were reports of after death home care visits
to only two children, who had been followed up by the institu-
tion’s home care program. After death care during mourning is
also an important intervention in palliative care and produces
a positive impact on families.
Decisions on limitation of futile therapy should be shared
with patients and families,22 exactly as happened in this study.
In the one case in which there was a divergence between the
team and the family in spite of progression of the disease, the
patient continued to receive invasive interventions, such as
cardiopulmonary resuscitation.
Tonelli et al. evaluated the care proﬁle to pediatric patients
who progressed to death in the same hospital as the current
research. Participation of parents in discussions was observed
in only 20.8% of the cases.23 This fact differs from the results
obtained in this study, which found that discussions were had
with the parents of all children with disease progression. Some
hypotheses can be suggested to explain this difference. In the
study by Tonelli et al., the deaths of all pediatric patients at
the hospital were evaluated, including patients with different
diseases and in different units, such as in the intensive care
unit and operating rooms.23
Another factor that might have facilitated discussing
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ample already had a bond with the medical team, which can
e seen by the interval between the diagnosis of the underlying
isease and death.24
It should also be stressed that in recent years medical
ractice has undergone a cultural change: the paternalistic
pproach has been replaced by an approach that recognizes
he role and importance of the family and the patient.25
One of the possible factors that accounts for this paradigm
hift is the current Brazilian Code of Medical Ethics, which
tresses the duty of doctors to “provide palliative care for patients
ith incurable and terminal diseases without undertaking useless
herapeutic actions and always taking into consideration the patient’s
anifested wish or, should it prove impossible, the wish of his/her
egal representative”.26
Limiting invasive therapy means excluding futile interven-
ions, which do not help to control the disease and do not
mprove the patient’s quality of life.22 Such limitations should
e individualized.6,22 The six tracheostomized patients of the
tudy can be regarded as examples of this. All of them under-
ent limitation of invasive therapy and three died without
echanical ventilatory support. For this reason, it is impor-
ant that the physician records what should or should not be
one, after having an appropriate conversation with the fam-
ly, rather than using vague terms such as “comfort measures”.
t should be noted that some terms were used inappropriately.
requently some doctors, when evaluating medical records,
onsidered the term “palliative care measures” to be similar
o “limitation of futile therapy”.
These ﬁndings reinforce the impression that there still
re heath workers who consider palliative care to be end-
f-life care.22 Some years ago, palliative and curative care
ere considered mutually exclusive approaches, and pallia-
ive care was only initiated after all curative possibilities had
een exhausted. Currently, they are complementary forms
f treatment and palliative care should be implemented at
he diagnoses of life-threatening diseases. Early integration
f these approaches facilitates discussion of sensitive issues
etween medical staff and families,27,28 in addition to improv-
ng the quality of life of patients.29
The limitations of this study are mainly related to the rela-
ively small number of cases and the lack of data on the deaths
hat took place at home or in other wards. However, medi-
al records with clear and comprehensible descriptions were
vailable. This is probably due to the fact that this is a teaching
ospital.
The results of this study show that the hospital where this
ork was carried out, despite not having a team specialized
n pediatric palliative care, meets most of the requirements
or implementing a speciﬁc program.6 In developing countries
uch as Brazil, there are still countless difﬁculties to follow-
p children with cancer. Delays in diagnoses and limited
esources are some of the obstacles found. Yet, such facts
hould not hinder the development of pediatric palliative
are programs, which should be given priority in tertiary
ospitals.3,11
The importance of managing pain and other symptoms
ppropriately is evident. For this approach to be truly effec-
ive, involvement of workers from different areas, with real
ntegration among them, is imperative. Other tools can also
eneﬁt this approach, such as the use of scales.
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Despite the involvement of several health workers caring
for the patients included in the study and the discussions
with most of them about limiting invasive therapy, the medi-
cal records did not include descriptions of a well-thought-out
treatment plan. This plan consists of discussing with patients
and families in advance about what kind of assistance will be
delivered. It should not address only medical aspects, but also
social issues such as what and who is important to the child
and his or her family. This planning should be reassessed as
required by changes in the clinical status.6
Training communication skills, developing the ability to
interact with other workers, learning to cope with the difﬁ-
culties intrinsic to the process of death are among the items
that should be improved.27 In this way, great quality assistance
will be delivered to patients throughout the process of disease
regardless of whether the ﬁnal outcome is cure or death.
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